Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia. (Q48507834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Roberto Ceravolo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Daniela Frosini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

D Volterrani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Bernardini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C Rossi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C Logi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Manca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

L Kiferle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Mariani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

L Murri

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

14 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1787-1790

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

The association of incident dementia with mortality in PD.

29 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-006-0478-6

Cholinergic dysfunction in diseases with Lewy bodies.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-006-0478-6

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

12 December 2020

Recent finding on dopaminergic transmission in the basal ganglia

1 reference

12 December 2020

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

12 December 2020

Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.

1 reference

12 December 2020

Efficacy and safety of donepezil in the treatment of executive dysfunction in Parkinson disease: a pilot study

1 reference

12 December 2020

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

1 reference

12 December 2020

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

1 reference

12 December 2020

Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease

1 reference

12 December 2020

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

12 December 2020

Rivastigmine (Exelon) for dementia in patients with Parkinson's disease

1 reference

12 December 2020

Clinical predictors of response to Acetyl Cholinesterase Inhibitors: experience from routine clinical use in Newcastle

1 reference

12 December 2020

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

1 reference

12 December 2020

Cognitive dysfunction and dementia in Parkinson's disease

1 reference

12 December 2020

Rivastigmine for dementia associated with Parkinson's disease

1 reference

12 December 2020

Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.

1 reference

12 December 2020

Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease

1 reference

12 December 2020

Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia

1 reference

12 December 2020

Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems

1 reference

12 December 2020

Benefits of rivastigmine on attention in dementia associated with Parkinson disease

1 reference

12 December 2020

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

1 reference

12 December 2020

Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease

1 reference

12 December 2020

Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients

1 reference

12 December 2020

Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs

1 reference

12 December 2020

10.1007/S00702-006-0478-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758132%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference